NEW YORK, NY / ACCESSWIRE / May 3, 2020 / Pomerantz LLP is investigating claims on behalf of investors of LogicBio Therapeutics, Inc. ("LogicBio" or the "Company") (LOGC). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. The investigation concerns whether LogicBio and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.